This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Institut De Cancerologie De L'ouest, National Institute of Health and Medical Research. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 5,383 
1 out of 6 
1 out of 1,853 
Years Active: 2023
Title: Innovations of Julien Fleurence in Cancer Therapy
Introduction
Julien Fleurence is a notable inventor based in Nantes, France. He has made significant contributions to the field of cancer therapy through his innovative research and development. His work focuses on improving the therapeutic potential of drugs using specific antibodies.
Latest Patents
Julien Fleurence holds a patent titled "Use of antibody against O-acetylated GD2 ganglioside to improve the therapeutic potential of drugs." This patent discloses a method for delivering an anti-cancer agent into a cell that expresses the OAcGD2 ganglioside by utilizing an antibody that recognizes this specific ganglioside. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Throughout his career, Julien Fleurence has worked with prominent organizations such as Ogd2 Pharma and Nantes Université. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Julien has collaborated with notable coworkers, including Stéphane Birkle and Sébastien Faraj. These partnerships have enriched his research and expanded the impact of his innovations in cancer treatment.
Conclusion
Julien Fleurence's work exemplifies the intersection of innovation and healthcare. His patent and collaborations reflect his dedication to improving cancer therapies, making a significant impact in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile